Industry Verticals »

All Categories

Insights »

About TMR »

Hemoglobin A1c Testing Market

Hemoglobin A1c Testing Market (Technology: Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays, Others; End User: Laboratory Testing (Commercial Laboratories, Others), Point-of-Care (POC) Testing [Hospitals, Homecare, Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to the latest report published by Transparency Market Research on the global hemoglobin A1c testing market for the historical year of 2017 and forecast period of 2019 to 2027, increase in the demand for point-of-care testing for the diagnosis of diabetes, high prevalence of diabetes, and launch of automated hemoglobin A1c testing analyzers are expected to boost the growth of the global hemoglobin A1c testing market during the forecast period.
  • The global hemoglobin A1c testing market was valued at ~US$ 1 Bn in 2018, and is expected to expand at a CAGR of ~9% during the forecast period.

Increase in Prevalence of Diabetes: A Key Driver

  • Diabetes is a common health condition among the geriatric population, the prevalence of which is expected to increase over the next few years. This high prevalence of diabetes is expected to drive the growth of the hemoglobin A1c testing market during the forecast period.
  • According to the National Institutes of Health, 8.5% of the people (617 million) across the world were aged 65 years or above in 2016, and this percentage is projected to increase to nearly 17% (1.6 billion) by 2050.
  • In Europe, there has been an exponential increase in the number of patients with diabetes. This can be attributed to obesity, sedentary lifestyle, and unhealthy diet among adults in the region.
  • According to the International Diabetes Federation, over 66 million people had diabetes in Europe in 2017, and the number is likely to rise to 81 million by 2045. There were 7,476,800 cases of diabetes in Germany in 2017. Furthermore, 286,000 children had diabetes in 2017, and each year, 28,600 children are diagnosed with diabetes.
  • These factors have led to the increase in healthcare expenditure, which was US$ 207 Bn in 2017, and is likely to increase to US$ 214 Bn by 2045.

Popularity of Ion-exchange High Performance Liquid Chromatography (HPLC)

  • The ion-exchange high performance liquid chromatography (HPLC) segment dominated the global hemoglobin A1c testing market in 2018, and is expected to account for the largest market share during the forecast period, as this technology is most widely used for hemoglobin A1c testing, and provides accurate HbA1c values in the presence of hemoglobin variants in case of a highly diversified population. HPLC increases the ionic strength of buffer, identifies variants, and consumes less time.
  • Most of the devices available in the market are based on HPLC, and the technology is preferred for hemoglobin A1c testing. HPLC-based hemoglobin A1c testing analyzers can also be used in point-of-care settings, along with laboratories. In December 2015, ARKRAY, Inc. launched a glucose analyzer named 'ADAMS Glucose GA-1172', and a glycohemoglobin analyzer called 'ADAMS A1c HA-8182', to determine blood sugar and hemoglobin A1c levels in patients. The glycohemoglobin analyzer ADAMS A1c HA-8182 is based on HPLC, and provides accurate results.

North America Prominent Hemoglobin A1c Testing Market

  • North America accounted for a major share of the global hemoglobin A1c testing market in 2018, followed by Europe. Increase in the number of point-of-care testing analyzers receiving approval from the Food & Drug Administration (FDA), new product launches, and rise in the adoption of newer technologies for hemoglobin A1c testing are various factors that are expected to drive the hemoglobin A1c testing market in the region.
  • In January 2019, PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) had cleared a medical device convenience kit that quantitatively measures the percent of glycated hemoglobin, total cholesterol, high-density lipoprotein, triglycerides, and glucose in whole blood.
  • In April 2014, Abbott Laboratories received FDA approval for ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test to help physicians in diagnosing and monitoring diabetes.
  • In Europe, the hemoglobin A1c testing market is expected to gain traction during the forecast period. The growth of the market in the region can be attributed to the increase in prevalence of diabetes, product approvals in the European Union (EU), and availability of automated hemoglobin A1c analyzers for laboratory settings.
  • In January 2018, Abbott Laboratories received CE approval for new Alinity h-series integrated system for hematology A1c testing. New Alinity h-series has combined features of Alinity hq and Alinity hs.
  • In April 2018, Beckman Coulter obtained CE mark for its DxH 520 hematology analyzer, which is a closed-tube, 5-part differential system for small-volume labs. In April 2018, ABL9 blood analyzers won the 'IF DESIGN AWARD 2018'.
  • The hemoglobin A1c testing market in Asia Pacific is estimated to grow at a faster pace than other regions during the forecast period, due to increase in the number of laboratory testing for diabetes, presence of well-qualified healthcare staff such as diabetologists and clinicians, and growing burden of diabetes.
  • According to the International Diabetes Federation (IDF), approximately 382 million people across the globe are expected to have diabetes by 2035, and of these, 60% will live in Asia and one-third in China.

Global Hemoglobin A1c Testing Market: Competition Landscape

  • Detailed profiles of manufacturers of hemoglobin A1c testing have been provided in the report to evaluate their key product offerings, financials, business strategies, and recent developments.
  • Key players operating in the global hemoglobin A1c testing market include
    • Abbott Laboratories
    • ARKRAY, Inc.
    • Bio-Rad Laboratories, Inc.
    • Polymer Technology Systems, Inc.
    • Danaher Corporation (Beckman Coulter)
    • F. Hoffmann-La Roche Ltd.
    • Menarini Group
    • Sebia
    • Siemens Healthineers
    • Tosoh Corporation
    • Trinity Biotech plc.

Global Hemoglobin A1c Testing Market: Key Developments

Major manufacturers in the global hemoglobin A1c testing market are adopting strategies of collaborations, partnerships, geographical expansion, distribution agreements, and new product development to strengthen their product portfolios and geographic presence in the global market. Key developments in the global hemoglobin A1c testing market are:

  • In December 2018, Arkray, Inc. established the Arkray Middle East Branch in Dubai, the UAE. Lifestyle diseases are on the rise in the Middle East due to rapid economic development in recent years and changes in lifestyle. As per the International Diabetes Federation (IDF), Saudi Arabia, the United Arab Emirates (UAE), Egypt, Bahrain, and Qatar were the top five countries with highest age-adjusted diabetes in 2017.
  • In January 2017, Abbott Laboratories announced the acquisition of St. Jude Medical, Inc., a global medical devices manufacturer. In October 2017, Abbott Laboratories acquired Alere Inc., a diagnostic device and service provider.
  • In October 2018, Beckman Coulter entered into a collaboration with Johns Hopkins Medicine. In June 2018, Beckman Coulter formed a strategic collaboration with the University of California, Irvine. In August 2016, Augusta University's medical center signed a 15-year service agreement with Danaher Corporation, the parent company of Beckman Coulter, to gain access to all diagnostic products and services of Danaher.

In the global hemoglobin A1c testing market report, we have discussed individual strategies, followed by company profiles of the manufacturers of hemoglobin testing devices. The ‘competition landscape’ section is included in the global hemoglobin A1c testing market report to provide readers with a dashboard view of key players operating in the global hemoglobin A1c testing market.

Frequently Asked Questions

What is the total market worth of hemoglobin A1c testing market?

Hemoglobin A1c testing market to reach US$ 4,117.7 Mn by 2027

What is the anticipated CAGR of the hemoglobin A1c testing market in the forecast period?

Hemoglobin A1c testing market to expand at a CAGR of ~9% from 2019 to 2027

What are the key driving factors for the growth of the hemoglobin A1c testing market?

Hemoglobin A1c testing market is driven by increase in the demand for point-of-care testing for the diagnosis of diabetes

Which is the rising prominent segment in the hemoglobin A1c testing market?

The ion-exchange high performance liquid chromatography (HPLC) segment dominated the global hemoglobin A1c testing market

Who are the key players in the hemoglobin A1c testing market?

Key players in the global hemoglobin A1c testing market include Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter)

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hemoglobin  A1c Testing Market

    3.1. Market Overview

    3.2. Introduction

    3.3. Product Definition

    3.4. Industry Evolution / Developments

4. Overview

    4.1. Market Dynamics

        4.1.1. Drivers

        4.1.2. Restraints

        4.1.3. Opportunities

    4.2. Global Hemoglobin A1c Testing Market Analysis and Forecast, 2017–2027

5. Key Insights

    5.1. Recent Approved Brands for HbA1c Test, 2018

    5.2. Global Hemoglobin A1c Testing Market: Regulations

    5.3. Quantitative Analysis, by Test Type

    5.4. Europe Hemoglobin A1c Testing Market Overview

6. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by Technology 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

        6.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

        6.3.2. Immunoassay

        6.3.3. Boronate Affinity Chromatography

        6.3.4. Direct Enzymatic Assay

        6.3.5. Others

    6.4. Global Hemoglobin  A1c Testing Market Attractiveness, by Technology 

7. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by End-user 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

        7.3.1. Laboratory Testing

            7.3.1.1. Commercial Laboratory 

            7.3.1.2. Others

        7.3.2. Point-of-Care (POC) Testing

            7.3.2.1. Hospitals

            7.3.2.2. Homecare

            7.3.2.3. Clinics

            7.3.2.4. Others

    7.4. Global Hemoglobin  A1c Testing Market Attractiveness, by End-user 

8. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Hemoglobin  A1c Testing Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Global Hemoglobin  A1c Testing Market Attractiveness, by Region

9. North America Hemoglobin  A1c Testing Market Analysis and Forecast

    9.1. Introduction

    9.2. Key Findings

    9.3. North America Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

        9.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

        9.3.2. Immunoassay

        9.3.3. Boronate Affinity Chromatography

        9.3.4. Direct Enzymatic Assay

        9.3.5. Others

    9.4. North America Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

        9.4.1. Laboratory Testing

            9.4.1.1. Commercial Laboratory 

            9.4.1.2. Others

        9.4.2. Point-of-Care (POC) Testing

            9.4.2.1. Hospitals

            9.4.2.2. Homecare

            9.4.2.3. Clinics

            9.4.2.4. Others

    9.5. North America Hemoglobin  A1c Testing Market Value Forecast, by Country, 2017–2027

        9.5.1. 1. U.S.

        9.5.2. Canada

    9.6. North America Hemoglobin  A1c Testing Market Attractiveness Analysis 

        9.6.1. By Technology 

        9.6.2. By End-user 

        9.6.3. By Country

10. Europe Hemoglobin  A1c Testing Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Europe Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

        10.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

        10.3.2. Immunoassay

        10.3.3. Boronate Affinity Chromatography

        10.3.4. Direct Enzymatic Assay

        10.3.5. Others

    10.4. Europe Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

        10.4.1. Laboratory Testing

            10.4.1.1. Commercial Laboratory 

            10.4.1.2. Others

        10.4.2. Point-of-Care (POC) Testing

            10.4.2.1. Hospitals

            10.4.2.2. Homecare

            10.4.2.3. Clinics

            10.4.2.4. Others

    10.5. Europe Hemoglobin  A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Europe Hemoglobin  A1c Testing Market Attractiveness Analysis 

        10.6.1. By Technology 

        10.6.2. By End-user 

        10.6.3. By Country/Sub-region

11. Asia Pacific Hemoglobin  A1c Testing Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Asia Pacific Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

        11.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

        11.3.2. Immunoassay

        11.3.3. Boronate Affinity Chromatography

        11.3.4. Direct Enzymatic Assay

        11.3.5. Others

    11.4. Asia Pacific Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

        11.4.1. Laboratory Testing

            11.4.1.1. Commercial Laboratory 

            11.4.1.2. Others

        11.4.2. Point-of-Care (POC) Testing

            11.4.2.1. Hospitals

            11.4.2.2. Homecare

            11.4.2.3. Clinics

            11.4.2.4. Others

    11.5. Asia Pacific Hemoglobin  A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Asia Pacific Hemoglobin  A1c Testing Market Attractiveness Analysis 

        11.6.1. By End-user 

        11.6.2. By Country/Sub-region

12. Latin America Hemoglobin  A1c Testing Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Latin America Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

        12.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

        12.3.2. Immunoassay

        12.3.3. Boronate Affinity Chromatography

        12.3.4. Direct Enzymatic Assay

        12.3.5. Others

    12.4. Latin America Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

        12.4.1. Laboratory Testing

            12.4.1.1. Commercial Laboratory 

            12.4.1.2. Others

        12.4.2. Point-of-Care (POC) Testing

            12.4.2.1. Hospitals

            12.4.2.2. Homecare

            12.4.2.3. Clinics

            12.4.2.4. Others

    12.5. Latin America Hemoglobin  A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Latin America Hemoglobin  A1c Testing Market Attractiveness Analysis 

        12.6.1. By Technology 

        12.6.2. By End-user 

        12.6.3. By Country/Sub-region

13. Middle East & Africa Hemoglobin  A1c Testing Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Middle East & Africa Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

        13.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

        13.3.2. Immunoassay

        13.3.3. Boronate Affinity Chromatography

        13.3.4. Direct Enzymatic Assay

        13.3.5. Others

    13.4. Middle East & Africa Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

        13.4.1. Laboratory Testing

            13.4.1.1. Commercial Laboratory 

            13.4.1.2. Others

        13.4.2. Point-of-Care (POC) Testing

            13.4.2.1. Hospitals

            13.4.2.2. Homecare

            13.4.2.3. Clinics

            13.4.2.4. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Middle East & Africa Hemoglobin  A1c Testing Market Attractiveness Analysis 

        13.6.1. By Technology 

        13.6.2. By End-user 

        13.6.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Market Share Analysis by Company (2018)

    14.3. Company Profiles

        14.3.1. Abbott Laboratories

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. ARKRAY, Inc.

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Strategic Overview

        14.3.3. Bio-Rad Laboratories, Inc.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Polymer Technology Systems, Inc.

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Strategic Overview

        14.3.5. Danaher Corporation (Beckman Coulter)

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. F. Hoffmann-La Roche Ltd.

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. Menarini Group

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Strategic Overview

        14.3.8. Sebia

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Strategic Overview

        14.3.9. Siemens Healthineers

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

        14.3.10. Tosoh Corporation

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Financial Overview

            14.3.10.3. Product Portfolio

            14.3.10.4. SWOT Analysis

            14.3.10.5. Strategic Overview

        14.3.11. Trinity Biotech plc.

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Financial Overview

            14.3.11.3. Product Portfolio

             14.3.11.4. SWOT Analysis

             14.3.11.5. Strategic Overview

List of Tables

Table 01: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 02: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 03: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

Table 04: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-care (POC) Settings, 2017–2027

Table 05: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Region, 2016–2026

Table 06: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 07: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 08: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 09: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

Table 10: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

Table 11: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 12: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 13: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 14: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

Table 15: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

Table 16: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 18: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 19: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

Table 20: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

Table 21: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 23: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 24: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

Table 25: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

Table 26: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 27: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 28: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 29: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

Table 30: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

List of Figures

Figure 01: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 02: Global Market Value Share, by Technology, 2018

Figure 03: Global Market Value Share, by Point-of-Care (POC) Settings, 2018

Figure 04: Global Market Value Share, by End-user, 2018

Figure 05: Global Market Value Share, by Region, 2018

Figure 06:  Global Market Share (% ) of Laboratory Test & POC Test, 2018

Figure 07:  Global Market Share (% ) of Laboratory Test & POC Test, 2027

Figure 08: Global  POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 09: North America POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 10: Europe POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 11: Asia Pacific POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 12: Latin America POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 13: Middle East & Africa POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 14: Global Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

Figure 15: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ion-exchange HPLC, 2017–2027

Figure 16: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunoassay, 2017–2027

Figure 17: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Boronate Affinity Chromatography, 2017–2027

Figure 18: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Direct Enzymatic Assay, 2017–2027

Figure 19: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027

Figure 20: Global Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

Figure 21: Global Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2026

Figure 22: Global Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

Figure 23: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Laboratories, 2017–2027

Figure 24: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Point-of-care (POC) Settings, 2017–2027

Figure 25: Global Hemoglobin A1c Testing Market Value Share, by Region, 2018 and 2027

Figure 26: Global Hemoglobin A1c Testing Market Attractiveness, by Region, 2018–2026

Figure 27: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 28: North America Hemoglobin A1c Testing Market Value Share, by Country, 2018–2027

Figure 29: North America Hemoglobin A1c Testing Market Attractiveness, by Country, 2019–2027

Figure 30: North America Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

Figure 31: North America Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

Figure 32: North America Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

Figure 33: North America Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

Figure 34: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 35: Europe Hemoglobin A1c Testing Market Value Share, by Country, 2018–2027

Figure 36: Europe Hemoglobin A1c Testing Market Attractiveness, by Country, 2019–2027

Figure 37: Europe Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

Figure 38: Europe Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

Figure 39: Europe Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

Figure 40: Europe Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

Figure 41: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 42: Asia Pacific Hemoglobin A1c Testing Market Value Share, by Country/Sub-Region, 2018 and 2027

Figure 43: Asia Pacific Hemoglobin A1c Testing Market Attractiveness, by Country/Sub-Region, 2019–2027

Figure 44: Asia Pacific Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

Figure 45: Asia Pacific Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

Figure 46: Asia Pacific Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

Figure 47: Asia Pacific Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

Figure 48: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 49: Latin America Hemoglobin A1c Testing Market Value Share, by Country/Sub-Region, 2018 and 2027

Figure 50: Latin America Hemoglobin A1c Testing Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 51: Latin America Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

Figure 52: Latin America Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

Figure 53: Latin America Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

Figure 54: Latin America Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

Figure 55: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 56: Middle East & Africa Hemoglobin A1c Testing Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 57: Middle East & Africa Hemoglobin A1c Testing Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 58: Middle East & Africa Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

Figure 59: Middle East & Africa Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

Figure 60: Middle East & Africa Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

Figure 61: Middle East & Africa Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

Figure 62: Global Hemoglobin A1c Testing Market Analysis, by Top Company Ranking, 2017

Figure 63: Tosoh Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 64: Tosoh Corporation Research & Development Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 65: Tosoh Corporation Breakdown of Net Sales (% Share), by Business Segment (2018)

Figure 66: Tosoh Corporation Breakdown of Net Sales (% Share), by Region (2018)

Figure 67: Bio-Rad Laboratories, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018

Figure 68: Bio-Rad Laboratories, Inc. Breakdown of Net Sales (% Share), by Business Segment (2018)

Figure 69: Trinity Biotech plc.  Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 70: Trinity Biotech plc. Research & Development Expenses, 2015–2018

Figure 71: Trinity Biotech plc. Breakdown of Net Sales (% Share), by Business Segment (2018)

Figure 72: Trinity Biotech plc. Breakdown of Net Sales (% Share), by Region (2018)

Figure 73: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 74: Abbott Laboratories R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 75: Abbott Laboratories Breakdown of Net Sales (% Share), by Business Segment, 2018

Figure 76: Abbott Laboratories Breakdown of Net Sales (% Share), by Region, 2018

Figure 77: F. Hoffmann-La Roche Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 78: F. Hoffmann-La Roche Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 79: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (% Share), by Business Segment, 2018

Figure 80: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (% Share), by Region, 2018

Figure 81: Danaher Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 82: Danaher Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017 

Figure 83: Danaher Corporation Breakdown of Net Sales (% Share), by Business Segment, 2018

Figure 84: Danaher Corporation Breakdown of Net Sales (% Share), by Geography, 2018

Figure 85: Siemens Healthineers Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 86: Siemens Healthineers Research and Development Expenses, 2015–2018

Figure 87: Siemens Healthineers Breakdown of Net Sales (% Share), by Business Segment, 2018

Figure 88: Siemens Healthineers Breakdown of Net Sales (% Share), by Region, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Hemoglobin A1c Testing Market

Schedule a Call